Filing Details

Accession Number:
0001127602-13-023234
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-07-23 08:32:44
Reporting Period:
2013-07-19
Filing Date:
2013-07-23
Accepted Time:
2013-07-23 08:32:44
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
820096 Perrigo Co PRGO Pharmaceutical Preparations (2834) 382799573
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1267878 W Todd Kingma C/O Perrigo Company
515 Eastern Avenue
Allegan MI 49010
Executive Vp, General Counsel No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-07-19 1,250 $35.85 18,315 No 4 M Direct
Common Stock Disposition 2013-07-19 1,250 $129.37 17,065 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option Right to Buy Disposition 2013-07-19 1,250 $0.00 1,250 $35.85
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
6,355 2018-08-25 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 961 Indirect By Trust
Footnotes
  1. This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on December 7, 2012. This 10b5-1 sales plan will expire on the close of business December 31, 2013.
  2. By Trust, of which the reporting person is the Trustee.
  3. Exercisable in 3 equal annual installments beginning 8/25/09.